Is it hype?

Attention moves fast; evidence moves slowly. A surging position with thin evidence is the classic gap. Positions are derived from momentum × evidence trajectory, not vibes (how this is computed).

InterventionPositionLagWhat it means
Ashwagandhasurginglargeashwagandha — attention is ahead of the evidence
Vitamin Dsurginglargevitamin D — claims outrun the trial evidence
Probioticssurginglargeprobiotics — marketing outpaces the strain-specific evidence
Turmericsurginglargeturmeric — attention well ahead of the human evidence
Collagensurginglargecollagen — booming; the evidence is early and often industry-funded
NMNsurginglargeNMN — anti-aging hype far ahead of any human outcome data
Lion's Maneemerginglargelion's mane — early hype, thin evidence
L-Theanineemergingmoderatel-theanine — rising in focus stacks; evidence still early
Rhodiolaemerginglargerhodiola — rising among adaptogens; thin evidence
Berberineevidence catching-upmoderateberberine — 'nature's Ozempic' hype, but the glucose evidence is real and growing
Magnesiumsettledsmallmagnesium — evidence and attention roughly aligned
Creatinesettledsmallcreatine — well-established; the public is catching up to the breadth of the evidence
Melatoninsettledmoderatemelatonin — established for sleep onset; dosing myths persist
St. John's WortsettledsmallSt. John's Wort — established for mild depression; interaction-heavy
Caffeinesettledsmallcaffeine — well-studied; evidence and use are aligned
Zincsettledsmallzinc — established for cold duration at the right dose and timing
5-HTPsettledsmall5-HTP — niche; modest evidence and a real serotonergic interaction risk
Omega-3decliningmoderateomega-3 — attention cooling after large mixed/null trials
Ginkgodecliningmoderateginkgo — memory claims faded after null prevention trials
Vitamin Cdebunkedlargevitamin C for colds — popular belief, evidence says otherwise
Glucosaminedebunkedlargeglucosamine — once popular for joints; independent trials largely disappointed